Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
J Nat Prod ; 75(3): 385-93, 2012 Mar 23.
Article in English | MEDLINE | ID: mdl-22324723

ABSTRACT

Toward the objective of designing a structurally modified analogue of the combretastatin A-4 phosphate prodrug (1b) with the potential for increased specificity toward thyroid carcinoma, synthesis of a series of iodocombstatin phosphate (11a-h) and diiodocombstatin phosphate prodrugs (12a-h) has been accomplished. The diiodo series was obtained via 8a and 9c from condensation of 4 and 6, and the iodo sequence involved a parallel pathway. Both series of iodocombstatins were found to display significant to powerful inhibition of the growth of a panel of human cancer cell lines and of the murine P388 lymphocytic leukemia cell line. Of the diiodo series, 12a was also found to markedly inhibit growth of pediatric neuroblastoma, and monoiodocombstatin 9a strongly inhibited HUVEC growth. Overall, the strongest activity was found against the breast, CNS, leukemia, lung, and prostate cancer cell lines and the least activity against the pancreas and colon lines. Parallel biological investigations of tubulin interaction, antiangiogenesis, and antimicrobial effects were also conducted.


Subject(s)
Antineoplastic Agents/chemical synthesis , Hydrocarbons, Iodinated/chemical synthesis , Hydrocarbons, Iodinated/pharmacology , Organophosphorus Compounds/chemical synthesis , Prodrugs/chemical synthesis , Stilbenes/chemical synthesis , Animals , Antineoplastic Agents/chemistry , Antineoplastic Agents/pharmacology , Child , Drug Screening Assays, Antitumor , Female , Human Umbilical Vein Endothelial Cells/drug effects , Humans , Hydrocarbons, Iodinated/chemistry , Male , Mice , Microbial Sensitivity Tests , Molecular Structure , Organophosphorus Compounds/chemistry , Organophosphorus Compounds/pharmacology , Prodrugs/chemistry , Prodrugs/pharmacology , Stilbenes/chemistry , Stilbenes/pharmacology
2.
Nat Prod Res ; 20(6): 611-28, 2006 May 20.
Article in English | MEDLINE | ID: mdl-16835096

ABSTRACT

Marine Natural Products (MNPs), such as bryostatin 1, are exposed to a range of physical and chemical conditions through the life cycle of the host organism. These include exposure to sunlight, oxidizing and reducing agents, cation binding, and adsorption to reactive metal oxide surfaces. Using Fourier Transform-Ion Cyclotron Resonance (FT-ICR), Matrix Assisted Laser Desorption Ionization Mass Spectrometry (MALDI-MS), UV/Vis absorbance spectroscopy, and molecular modeling, we studied the impact of UV light, TiO2, I2, and reaction with FeCl3 on the structure of bryostatin 1. Our results demonstrate that natural conditions transform bryostatin to a number of structures, including one with a molar mass of 806 Da, which we have previously identified in the sediment collected from the Gulf of Mexico. To date, at least 20 different structures of bryostatin have been reported in the literature. This work suggests that these variations may be products of the chemical environment in which the bryozoa Bugula neritina resides and are not the result of genetic variations within Bugula.


Subject(s)
Bryozoa/chemistry , Ecosystem , Macrolides/chemistry , Animals , Bryostatins , Bryozoa/metabolism , Chlorides , Computer Simulation , Ferric Compounds/chemistry , Iodine/chemistry , Macrolides/metabolism , Molecular Structure , Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization , Spectrophotometry, Ultraviolet , Titanium/chemistry , Ultraviolet Rays
SELECTION OF CITATIONS
SEARCH DETAIL
...